Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HH-006 in Chronic Hepatitis B Virus Infection
NCT07519330Phase 2Recruiting
- Sponsor
- Huahui Health
- Start
- May 2026
- Primary completion
- Feb 2028
- Modality
- Engineered Antibody Formats, Antibody Conjugates, Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of HH-006 in chronic hepatitis B virus infection (CHB), sponsored by Huahui Health. Started May 2026; status: recruiting.
02
Drugs
HH-006
03
Conditions
chronic hepatitis B virus infection (CHB)
Beyond the preview
Go deeper on NCT07519330.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07519330.